查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1357983

伤寒口服疫苗市场：按疫苗类型、按年龄层、按配销通路、按最终用户、按地区

Oral Typhoid Vaccine Market, By Vaccine Type, By Age Group, By Distribution Channel, By End-User, By geography
出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

伤寒口服疫苗市场规模预计将从 2023 年的 3,946.2 亿美元增至 2030 年的 8,888.7 亿美元，预测期内年复合成长率为 12.3%。

报告范围 报告详情
基准年 2022年 2023年市场规模 3946.2亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期年复合成长率 12.30% 2030年市场规模预测 8888.7亿美元
伤寒口服疫苗全球市场占有率(%)，按地区，2023 年
口服伤寒疫苗市场-IMG1

伤寒是感染疾病，仍然是一个主要的全球健康问题，特别是在开发中国家。每年报告的病例超过 1000 万例，考虑有效的预防措施至关重要，其中之一就是口服伤寒疫苗。

口服伤寒疫苗，也称为Ty21a，因其预防伤寒的便利性和有效性而受到欢迎。与传统的注射疫苗不同，这种创新疫苗是口服给药，因此更容易分发和给药，特别是在医疗保健设施有限的地区。

市场动态：

伤寒口服疫苗市场是由多种要素推动的。首先，全球伤寒罹患率不断上升，需要采取有效的预防措施，增加了口服伤寒疫苗的需求。此外，人们对疫苗接种好处和公共卫生配合措施重要性的认识不断提高也促进了市场的成长。

但市场也存在一定的抑制因素。这些挑战之一是许多地区获得卫生服务的机会有限，阻碍了口服伤寒疫苗的分发和给药。此外，生产和分发疫苗的高成本也对覆盖服务不足的人构成了障碍。

儘管有这些挑战，伤寒口服疫苗市场仍具有广泛的成长机会。开发具有成本效益的製造流程和简化的分销网络有助于克服准入障碍。此外，为提高口服伤寒疫苗的功效和安全性而进行的研究和开发工作也正在推动市场扩张。

本研究的主要特点

  • 本报告对全球口服伤寒疫苗市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030年）的市场规模和平均年度（年复合成长率 %）。
  • 它还揭示了各个细分市场的潜在收入机会，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场促进因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球伤寒口服疫苗市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
  • 全球伤寒口服疫苗市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球伤寒口服疫苗市场的各种策略矩阵来促进他们的决策。

目录

第1章调查目的和假设

  • 这项研究的目的
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第3章市场动态、法规及趋势分析

  • 市场动态
    • 人们越来越认识到疫苗接种的好处
    • 低收入地区的准入受到限制
    • 扩大新兴国家的免疫规划
  • 影响分析
  • 主要亮点
  • 法规场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第4章伤寒口服疫苗市场－冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第5章伤寒口服疫苗市场：依疫苗类型，2023-2030

  • 减毒活病毒疫苗
  • 灭活疫苗

第6章伤寒口服疫苗市场：依年龄划分，2023-2030

  • 儿科疫苗
  • 成人疫苗

第7章伤寒口服疫苗市场：依配销通路划分，2023-2030 年

  • 医院和诊所
  • 药房和零售店
  • 政府疫苗接种计划

第8章伤寒口服疫苗市场：以最终用户划分，2023-2030 年

  • 旅游
  • 流行地区居民
  • 医护人员

第9章伤寒口服疫苗市场：依地区划分，2023-2030年

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第10章竞争形势

  • Sanofi Pasteur
  • Bharat Biotech
  • Pfizer Inc.
  • GlaxoSmithKline（GSK）
  • Baxter International Inc.
  • Merck & Co., Inc.（MSD outside North America）
  • Takeda Pharmaceutical Company Limited
  • Novartis International AG
  • Biological E. Limited
  • Others

第11章章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6332

The Oral Typhoid Vaccine Market size is expected to reach US$ 888.87 Billion by 2030, from US$ 394.62 Billion in 2023, at a CAGR of 12.3% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 394.62 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 12.30% 2030 Value Projection: US$ 888.87 Bn
Global Oral Typhoid Vaccine Market Share (%), by Region, 2023
Oral Typhoid Vaccine Market - IMG1

Typhoid fever, an infectious disease caused by the bacterium Salmonella typhi, remains a significant global health concern, particularly in developing countries. With over 10 million cases reported each year, it is crucial to explore effective preventive measures, one of which is the oral typhoid vaccine

The oral typhoid vaccine, also known as Ty21a, has gained popularity due to its convenience and effectiveness in preventing typhoid fever. Unlike traditional injectable vaccines, this innovative vaccine is administered orally, making it easier to distribute and administer, especially in areas with limited healthcare facilities.

Market Dynamics:

The oral typhoid vaccine market is driven by several factors. Firstly, the increasing global incidence of typhoid fever has created a need for effective preventive measures, thereby boosting the demand for oral typhoid vaccines. Additionally, the growing awareness about the benefits of vaccination and the importance of public health initiatives has contributed to market growth.

However, there are also certain restraints to the market. One such challenge is the limited access to healthcare services in many regions, hindering the distribution and administration of oral typhoid vaccines. Moreover, the high cost associated with vaccine production and distribution poses a barrier to reaching underserved populations.

Despite these challenges, the oral typhoid vaccine market holds promising opportunities for growth. The development of cost-effective manufacturing processes and streamlined distribution networks can help overcome access barriers. Furthermore, ongoing research and development efforts to enhance the efficacy and safety of oral typhoid vaccines can drive market expansion.

Key features of the study:

  • This report provides in-depth analysis of the global oral typhoid vaccine market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global oral typhoid vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Oral Typhoid Vaccine market include Sanofi Pasteur, Bharat Biotech, Pfizer Inc., and GlaxoSmithKline (GSK), among others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global oral typhoid vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oral typhoid vaccine market

Detailed Segmentation:

  • By Vaccine Type:
    • Live Attenuated Vaccine
    • Inactivated Vaccine
  • By Age Group:
    • Pediatric Vaccines
    • Adult Vaccines
  • By Distribution Channel:
    • Hospitals and Clinics
    • Pharmacies and Retail Outlets
    • Government Immunization Programs
  • By End-User:
    • Travelers
    • Residents of Endemic Areas
    • Healthcare Workers
  • By Geographic Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Top companies in Oral Typhoid Vaccine Market:
    • Sanofi Pasteur
    • Bharat Biotech
    • Pfizer Inc.
    • GlaxoSmithKline (GSK)
    • Baxter International Inc.
    • Merck & Co., Inc. (MSD outside North America)
    • Takeda Pharmaceutical Company Limited
    • Novartis International AG
    • Biological E. Limited
    • AstraZeneca
    • Cipla Limited
    • Prokarium
    • Bio-Med Pvt. Ltd.
    • Panacea Biotec
    • Dynavax Technologies Corporation
    • Butantan Institute
    • Zydus Cadila
    • Biomed Pvt. Ltd.
    • Cadila Healthcare Limited
    • GlaxoSmithKline Biologicals

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Oral Typhoid Vaccine, By Vaccine Type
    • Market Oral Typhoid Vaccine, By Age Group
    • Market Oral Typhoid Vaccine, By Distribution Channel
    • Market Oral Typhoid Vaccine, By End-User
    • Market Oral Typhoid Vaccine, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing awareness about the benefits of vaccination
    • Limited Access in Low-Income Regions
    • Expanding immunization programs in developing countries
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Oral Typhoid Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Oral Typhoid Vaccine Market , By Vaccine Type, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Live Attenuated Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Inactivated Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Oral Typhoid Vaccine Market , By Age Group, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Pediatric Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Adult Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

7. Oral Typhoid Vaccine Market , By Distribution Channel, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Pharmacies and Retail Outlets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Government Immunization Programs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

8. Oral Typhoid Vaccine Market , By End-User, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Travelers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Residents of Endemic Areas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
  • Healthcare Workers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)

9. Oral Typhoid Vaccine Market , By Region, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2018 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2023-2030,(US$ Bn)

10. Competitive Landscape

  • Sanofi Pasteur
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bharat Biotech
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • GlaxoSmithKline (GSK)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Baxter International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck & Co., Inc. (MSD outside North America)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Takeda Pharmaceutical Company Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novartis International AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biological E. Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Others
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us